Company / Working Capital
Coherus Oncology, Inc. Working Capital History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$228.0M
FY2019
5-year range
$51.2M / $228.0M
FY2015-FY2019
Trend
+345.6%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital changed +346% YoY in FY2019, a notable deviation from the 5-year average annual change of +58%.
Based on SEC 10-K filings.
$228M in FY2019 with a 5-year CAGR of +12.4%.
Improved from $117M to $228M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- +29.5%
- 5-Year CAGR
- +12.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +12.4%, indicating consistent growth.
- In FY2019, working capital increased 345.6% year-over-year.
- Lowest working capital in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $228.0M | +345.6% |
| FY2018 | $51.2M | -56.3% |
| FY2017 | $117.1M | +11.4% |
| FY2016 | $105.1M | +15.0% |
| FY2015 | $91.4M | -28.3% |
| FY2014 | $127.4M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026